BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laursen, M L
Right arrow Articles by Sjoelie, A K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laursen, M L
Right arrow Articles by Sjoelie, A K
Topic Collections
Right arrowRelevant Article
British Journal of Ophthalmology 2004;88:1173-1179
© 2004 BMJ Publishing Group Ltd


EXTENDED REPORT

Subthreshold micropulse diode laser treatment in diabetic macular oedema

M L Laursen1, F Moeller1, B Sander2, A K Sjoelie1

1 Department of Ophthalmology, Odense University Hospital, DK-5000, Odense C, Denmark
2 Department of Ophthalmology, Herlev Hospital, University of Copenhagen, DK-2730, Herlev, Denmark

Correspondence to:
Correspondence to:
Majbrit Lind Laursen MD
Department of Ophthalmology, Odense University Hospital, DK-5000, Odense C, Denmark; majbrit.lind.laursen{at}ouh.fyns-amt.dk

Background/aim: Enlargement of laser scars after retinal argon laser photocoagulation can give rise to deterioration in visual acuity. Subthreshold micropulse diode laser may decrease this risk. The aim of this study was to compare the effectiveness of subthreshold micropulse diode laser (810 nm) and conventional argon laser (514 nm) photocoagulation for the treatment of clinically significant macular oedema in diabetic patients.

Methods: 23 eyes of 16 patients were randomised to either treatment. Follow up was conducted for a minimum of 5 months. Changes in visual acuity and macular oedema measured by optical coherence tomography were examined.

Results: Visual acuity remained stable in all treatment groups throughout the observation period. Changes in retinal thickness were small both foveally and perifoveally. In patients with focal macular oedema a significant reduction in retinal thickness (9% ~ –26 µm, p = 0.02) was seen foveally 3 months after diode laser photocoagulation.

Conclusion: Subthreshold micropulse diode laser and conventional argon laser treatment showed an equally good effect on visual acuity. Subthreshold micropulse diode laser showed a stabilising or even improving effect on macular oedema. The combination of primary diode laser and supplementary argon laser might be particularly favourable in reducing diabetic macular oedema.


Abbreviations: CSMO, clinically significant macular oedema; FA, fluorescein angiography; OCT, optical coherence tomography; RPE, retinal pigment epithelium

Keywords: macular oedema; optical coherence tomography; argon laser photocoagulation; subthreshold micropulse diode laser photocoagulation; diabetic retinopathy


Relevant Article

BJO at a glance
Creig Hoyt
Br. J. Ophthalmol. 2004 88: 1105. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
M O'Doherty, I Dooley, and M Hickey-Dwyer
Interventions for diabetic macular oedema: a systematic review of the literature
Br. J. Ophthalmol., December 1, 2008; 92(12): 1581 - 1590.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
T J Desmettre, S R Mordon, D M Buzawa, and M A Mainster
Micropulse and continuous wave diode retinal photocoagulation: visible and subvisible lesion parameters
Br. J. Ophthalmol., June 1, 2006; 90(6): 709 - 712.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 by the BMJ Publishing Group Ltd.